However, the molecular mechanisms underlying the TBI-induced AD-like pathology (e.g., amyloid accumulation, tau aggregation, synaptic dysfunction, gliosis, neuronal loss, etc.)and the cognitive deficits remain unknown. The gene discussed is MAPT; the disease is Alzheimer disease.